Pharmaceuticals, Biotechnology and Life Sciences
Brings Total Outstanding Share Repurchase Authorization to Approximately $6.4 Billion NEW YORK–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that, on January 8, 2021, the…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly” or the “Company”), has executed a Letter…
– Announces strategic collaborations with Biogen, Genentech to develop RNAi therapeutics for neurodegenerative diseases – – Founders are world-leading experts…
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company has revised certain elements of its full year…
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company has revised certain elements of its full year…
Full year 2020 preliminary net revenues of $494.4 million, representing annual growth of 41 percent compared to 2019 Novocure to…
Full year 2020 preliminary net revenues of $494.4 million, representing annual growth of 41 percent compared to 2019 Novocure to…
– Announces strategic collaborations with Biogen, Genentech to develop RNAi therapeutics for neurodegenerative diseases – – Founders are world-leading experts…